DBMZX
Price
$30.85
Change
+$0.21 (+0.69%)
Updated
Jul 25 closing price
Net Assets
1.07B
PMAQX
Price
$48.54
Change
+$0.35 (+0.73%)
Updated
Jul 25 closing price
Net Assets
33.03B
Interact to see
Advertisement

DBMZX vs PMAQX

Header iconDBMZX vs PMAQX Comparison
Open Charts DBMZX vs PMAQXBanner chart's image
BNY Mellon Sm/Md Cp Gr Z
Price$30.85
Change+$0.21 (+0.69%)
VolumeN/A
Net Assets1.07B
Principal MidCap R6
Price$48.54
Change+$0.35 (+0.73%)
VolumeN/A
Net Assets33.03B
DBMZX vs PMAQX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
DBMZX vs. PMAQX commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DBMZX is a Buy and PMAQX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PMAQX has more cash in the bank: 33B vs. DBMZX (1.07B). PMAQX pays higher dividends than DBMZX: PMAQX (0.19) vs DBMZX (0.00). DBMZX was incepted earlier than PMAQX: DBMZX (8 years) vs PMAQX (9 years). DBMZX (0.88) is less costly to investors than PMAQX (0.59). DBMZX is a more actively managed with annual turnover of: 48.92 vs. PMAQX (10.50). PMAQX has a lower initial minimum investment than DBMZX: PMAQX (0) vs DBMZX (1000). DBMZX annual gain was more profitable for investors over the last year : 19.13 vs. PMAQX (13.16). PMAQX return over 5 years is better than : 57.67 vs. DBMZX (-5.55).
DBMZXPMAQXDBMZX / PMAQX
Total Expense Ratio0.830.59141%
Annual Report Gross Expense Ratio0.880.59149%
Fund Existence8 years9 years-
Gain YTD6.9837.97788%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.07B33B3%
Annual Yield % from dividends0.000.19-
Returns for 1 year19.1313.16145%
Returns for 3 years31.9649.7664%
Returns for 5 years-5.5557.67-10%
Returns for 10 years334.35N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CHSCP27.720.17
+0.62%
CHS
NLOP33.420.19
+0.57%
Net Lease Office Properties
CLDX23.350.13
+0.56%
Celldex Therapeutics
MUR26.13-0.20
-0.76%
Murphy Oil Corp
IPSC0.63-0.03
-5.17%
Century Therapeutics